Molecular-based haplotype analysis of the β 2-adrenergic receptor gene (ADRB2) in Japanese asthmatic and non-asthmatic subjects

Allergology International

Volumn 55, Issue 2, 2006, Pages 191-198

  Munakata, Mitsuru ^a   Harada, Yosuke ^b   Ishida, Takashi ^a   Saito, Junpei ^a   Nagabukuro, Akira ^b   Matsushita, Hiroshi ^b   Koga, Nobuyuki ^b   Ohsaki, Masaaki ^b   Imagawa, Kenichi ^b   Shiratsuchi, Takayuki ^b  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Asthma; Haplotype; Japanese population; SNPs; 2 adrenergic receptor

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR;

ALLELE; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; GENE FREQUENCY; GENE SEQUENCE; GENE STRUCTURE; GENETIC ANALYSIS; HAPLOTYPE; HUMAN; HUMAN CELL; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 33745675688     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.55.191     Document Type: Article

References (24)

1. Kleyn PW, Vesell ES. Genetic variation as a guide to drug development Science 1998;281:1820-1821.
2. Evans W, Relling M. Pharmacogenomics: translating functional genomics into rational therapeutics. Science 1999;286:487-491.
3. Lima J, Thomason D, Mohamed M et al. Impact of genetic polymorphisms of the beta 2-adrenergic receptor on albuterol bronchodilator pharmacodynamics. Clin. Pharmacol. Ther. 1999;65:519-525.
4. Hoehe M, Kopke K, Wendel B et al. Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence. Hum. Mol. Genet. 2000;9:2895-2908.
5. Drysdale C, McGraw D, Stack C et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc. Natl. Acad. Sci. U.S.A. 2000;97:10483-10488.
6. Ohe M, Munakata M, Hizawa N et al. Beta 2-adrenergic receptor gene restriction fragment length polymorphism and bronchial asthma. Thorax 1995;50:353-359.
7. Shek L, Tay A, Chew F et al. Genetic susceptibility to asthma and atopy among Chinese in Singapore: linkage to markers on chromosome 5q31-33. Allergy 2001;56:749-753.
8. Turki J, Pak J, Green S et al. Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma. Evidence that Gly 16 correlates with the nocturnal phenotype. J. Clin. Invest. 1995;95:1635-1641.
9. Weir T, Mallek N, Sandford A et al. Beta 2-adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am. J. Respir. Crit. Care Med. 1998;158:787-791.
10. Fowler S, Dempsey O, Sims E et al. Screening for bronchial hyperresponsiveness using methacholine and adenosine monophosphate. Relationship to asthma severity and beta (2)-receptor genotype. Am. J. Respir. Crit. Care Med. 2000;162:1318-1322.
11. Summerhill E, Leavitt S, Gidley H et al. Beta (2) - adrenergic receptor Arg16/Arg16 genotype is associated with reduced lung function, but not with asthma, in the Hutterites. Am. J. Respir. Crit. Care Med. 2000;162:599-602.
12. Ulbrecht M, Hergeth M, Wjst M et al. Association of beta (2)-adrenoreceptor variants with bronchial hyperresponsiveness. Am. J. Respir. Crit. Care Med. 2000;161:469-474.
13. Sato R. The role of β2-adernergic gene polymorphisms in asthma. Hokkaido J. Med. Sci. 2000;75:81-94.
14. Israel E, Chinchilli V, Ford J et al. Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial. Lancet 2004;364:1505-1512.
15. Goddard K, Hopkins P, Hall J et al. Linkage disequilibrium and allele-frequency distributions for 114 single-nucleotide polymorphisms in five populations. Am. J. Hum. Genet. 2000;66:216-234.
16. Gaedigk A, Casley W, Tyndale R et al. Cytochrome P4502C9 (CYP2C9) allele frequencies in Canadian Native Indian and Inuit populations. Can. J. Physiol. Pharmacol. 2001;79:841-847.
17. Ackerman H, Usen S, Mott R et al. Haplotypic analysis of the TNF locus by association efficiency and entropy. Genome. Biol. 2003;4:R24.
18. Cohen J, Levinson A. A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene. Nature 1988;334:119-124.
19. Hill W, Weir B. Maximum-likelihood estimation of gene location by linkage disequilibrium. Am. J. Hum. Genet. 1994;55:217.
20. Daniels S, Bhattacharrya S, James A et al. A genome-wide search for quantitative trait loci underlying asthma. Nature 1996;383:247-250.
21. Collaborative Study on the Genetics of Asthma. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nat. Genet. 1997;15:389-392.
22. Liggett S. Beta(2)-adrenergic receptor pharmacogenetics. Am. J. Respir. Crit. Care Med. 2000;161:S197-201.
23. Evans D, McLeod H, Pritchard S et al. Interethnic variability in human drug responses. Drug Metab. Dispos. 2001;606-610.
24. Hamdy S, Hiratsuka H, Narahara K et al. Allele and genotype frequencies of polymorphic DCP1, CETP, ADRB2, and HTR2A in the Egyptian population. Eur. J. Clin. Pharmacol. 2002;58:29-36.